VectivBio Holding AG expected to post a loss of 64  cents a share - Earnings Preview

VectivBio Holding AG

05/04/2022 13:38

* VectivBio Holding AG  VECT.OQ   VECT.O  is expected
to report
results on April 7.
    * ​Refinitiv's mean analyst estimate for VectivBio Holding
AG is
for a loss of 64 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for
the pharmaceuticals
peer group is  "Buy".​
    * Wall Street's median 12-month price target for VectivBio
Holding
AG is $23.5​, above​ its last closing price of $4.98. ​​​

This summary was machine generated April 5 at 12:38 GMT.  All
figures in US dollars  unless otherwise stated